FR2274314A1 - Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g. - Google Patents

Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g.

Info

Publication number
FR2274314A1
FR2274314A1 FR7420376A FR7420376A FR2274314A1 FR 2274314 A1 FR2274314 A1 FR 2274314A1 FR 7420376 A FR7420376 A FR 7420376A FR 7420376 A FR7420376 A FR 7420376A FR 2274314 A1 FR2274314 A1 FR 2274314A1
Authority
FR
France
Prior art keywords
bcg
vaccine
immunising
incorporation
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7420376A
Other languages
English (en)
French (fr)
Other versions
FR2274314B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METIANU TIBERE
Original Assignee
METIANU TIBERE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METIANU TIBERE filed Critical METIANU TIBERE
Priority to FR7420376A priority Critical patent/FR2274314A1/fr
Publication of FR2274314A1 publication Critical patent/FR2274314A1/fr
Application granted granted Critical
Publication of FR2274314B1 publication Critical patent/FR2274314B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7420376A 1974-06-12 1974-06-12 Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g. Granted FR2274314A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7420376A FR2274314A1 (fr) 1974-06-12 1974-06-12 Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7420376A FR2274314A1 (fr) 1974-06-12 1974-06-12 Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g.

Publications (2)

Publication Number Publication Date
FR2274314A1 true FR2274314A1 (fr) 1976-01-09
FR2274314B1 FR2274314B1 (enExample) 1978-07-21

Family

ID=9139963

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7420376A Granted FR2274314A1 (fr) 1974-06-12 1974-06-12 Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g.

Country Status (1)

Country Link
FR (1) FR2274314A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms

Also Published As

Publication number Publication date
FR2274314B1 (enExample) 1978-07-21

Similar Documents

Publication Publication Date Title
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
NZ218825A (en) Use of low dosages of interferon as adjuvants for vaccines
EP0438803A3 (en) Vaccines against cancer and infectious diseases
ES442892A1 (es) Un procedimiento para la produccion de una vacuna que cuandose inyecta en gatos es capaz de inmunizarlos contra el feli-ne calicivirus.
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
FR2274314A1 (fr) Renforcement du pouvoir immunisant des vaccins par adjonction du b.c.g.
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
HUP9901299A2 (hu) Attenuált, nemimmunogén poxvírusokból vagy parapoxvírusokból előállított multipotens parapox immunitást előidéző gyógyszerek használatának új indikációi
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
YAOI Treatment of whooping cough by combined vaccination of H. pertussis vaccine and purified vaccinia lymph (1)
Salvioli Killed anti-tuberculosis vaccine and hyaluronidase (diffusing vaccine)
Agnese Combined immunization against diphtheria, tetanus and pertussis in newborn infants, duration of antibody levels; antibody titers after booster dose; effect of passive immunity to diphtheria on active immunization with diphtheria toxoid
YAOI et al. TREATMENT OF WHOOPING COUGH BY COMBINED VACCINATION WITH H. PERTUSSIS VACCINE AND PURIFIED VACCINIA LYMPH (2)
YAOI et al. RESULT OF ACTIVE IMMUNIZATION AGAINST PERTUSSIS BY COMBINED H. PERTUSSIS VACCINE AND VACCINIA VIRUS, PERFORMED AT VILLAGES IN KANAGAWA PREFECTURE
USD237728S (en) Toy beauty salon
Vahlquist et al. Active Basal Immunity and Its Application to Epidemiology III. Combined Immunization against Diphtheria, Tetanus, and Pertussis in Infancy
Talyzina About intravenous vaccine therapy for brucellosis in children
Blatt et al. INTRADERMAL IMMUNIZATION: II. DIPHTHERIA
FR2287912A1 (fr) Derives de polysaccharide portant des groupements amines, leurs procedes de preparation et leurs applications en tant qu'agents adjuvants de l'immunite non specifique
Urguyev et al. Associated live vaccine against anthrax and blackleg.
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
Hobson Current vaccination procedures against influenza
ABT et al. DIPHTHERIA IMMUNIZATION: THE PERCUTANEOUS METHOD OF LOEWENSTEIN

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse